Names and Identifiers

• • O-Acetyl Losartan
  • [2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methyl acetate
  • 2-Butyl-4-chloro-(1-{[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methyl acetate
  • 2-Butyl-4-chloro-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-imidazole-5-methanol 5-acetate
  • 2-Butyl-4-chloro-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-methanol 5-acetate
  • Losartan EP IMpurity J
  • Losartan Impurity J (EP)
  • Losartan EP IMpurity J (O-acetyl Losartan)
  • [2-Butyl-4-chloro-1-[[2'-(1Htetrazol-5-yl)biphenyl-4-yl] Methyl]-1HiMidazol-5-yl]Methyl Acetate
  • (1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-butyl-4-chloro-1H-imidazol-5-yl)methyl acetate
  • [2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazol-5-yl]methyl Acetate
  • Losartan Impurity J
  • 1006062-27-6
  • (2-Butyl-4-chloro-1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-imidazol-5-yl)methyl acetate
  • 1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-((2'-(2H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, 5-acetate-
  • BCP28002
  • Q27293596
  • SCHEMBL4657793
  • o-acethyllosartan
  • DTXSID60143427
  • UNII-X65NI9XVQ4
  • LOSARTAN POTASSIUM IMPURITY J [EP IMPURITY]
  • X65NI9XVQ4
  • Losartan potassium specified impurity J [EP]
  • AKOS030240964
  • 1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, 5-acetate
  • G79250
  • J-000178
  • AKOS025117611
  • +expand
• • Inchi： 1S/C24H25ClN6O2/c1-3-4-9-22-26-23(25)21(15-33-16(2)32)31(22)14-17-10-12-18(13-11-17)19-7-5-6-8-20(19)24-27-29-30-28-24/h5-8,10-13H,3-4,9,14-15H2,1-2H3,(H,27,28,29,30)
  • InChI Key： HIUYRCVDCVFSBP-UHFFFAOYSA-N
  • SMILES： ClC1=C(COC(C)=O)N(CC2C=CC(C3=CC=CC=C3C3N=NNN=3)=CC=2)C(CCCC)=N1

Computed Properties

Experimental Properties